Physician profile

Daniel C Williams

Internal Medicine · Tunkhannock, PA

NPI 1609869072

$9,004.41

in general payments reported to CMS, 2019-2025

33 companies · $1,476 in 2025

The $1,476 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,411.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $1,965.59 2019-2025 Breztri, Farxiga, Airsupra
Lilly USA, LLC $1,498.89 2019-2025 Mounjaro, Jardiance, Zepbound
Novo Nordisk INC $1,428.97 2019-2025 Ozempic, Rybelsus, Wegovy
Abbvie INC. $995.30 2021-2025 Vraylar, Linzess, Creon
Merck Sharp & Dohme LLC $430.30 2019-2025 Gardasil 9, Vaxneuvance, Vaxelis
Boehringer Ingelheim Pharmaceuticals, INC. $319.90 2019-2025 Jardiance, Synjardy
Pfizer INC. $287.62 2020-2025
Janssen Pharmaceuticals, INC $269.12 2019-2022
Amgen INC. $212.73 2019-2025 Otezla, Repatha, Otezla
Abbott Laboratories $179.54 2021-2025 Freestyle Libre 3, Freestyle Libre 2
Exact Sciences Corporation $168.10 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Aimmune Therapeutics, INC. $153.30 2024-2025 Zenpep
Nestle Healthcare Nutrition INC. $120.93 2023
Takeda Pharmaceuticals U.S.A., INC. $120.04 2019-2022
Philips North America LLC $106.70 2020-2023
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $102.78 2019-2020
Dexcom, INC. $101.55 2022-2025 Dexcom G6 Transmitter
E.R. Squibb & Sons, L.L.C. $98.21 2019-2023 Eliquis
Biohaven Pharmaceutical Holding Company Ltd. $70.65 2022
Sanofi Pasteur INC. $70.15 2019-2023
Glaxosmithkline, LLC. $62.83 2019-2022
Lundbeck LLC $35.97 2022
Kowa Pharmaceuticals America, INC. $33.82 2025 Zoryve
Biogen, INC. $31.15 2021-2022
Teva Pharmaceuticals USA, INC. $26.93 2019-2022
Antares Pharma, INC. $17.00 2022
Sanofi-Aventis U.S. LLC $16.30 2021
Phathom Pharmaceuticals, INC. $15.12 2025 Voquezna
Biohaven Pharmaceuticals, INC. $14.93 2021
Eisai INC. $13.20 2024
Amarin Pharma, INC. $12.62 2020
Esperion Therapeutics, INC. $12.62 2020
Boston Scientific Corporation $11.55 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel C Williams

$9,004.41

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,476 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/117599/daniel-c-williams

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.